The company that specializes in the use of cannabis as a form of medication has come up with a revolutionary pain patch that could be used to treat diabetic nerve pain and symptoms of fibromyalgia. This might change the way cannabis is seen in the medical world forever.
The new medications have been designed to be administered as transdermal patches, and they are basically adhesive patches that are stuck to the skin and they release certain chemicals over time in order to help fight the neurological nerve pain that is associated with diabetes and fibromyalgia. With this medium means a controlled dose of the medication could be administered on a daily basis, without negative side effects discovered so far.
Cannabis Science, the company that originally designed the patches, said:
“Promote healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as topical, oral, intramuscular, intravenous, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through a body heat melting thin layers of medication embedded in the adhesive which will contain high potency cannabinoid (CBD) extract that slowly enters into the bloodstream and then it penetrates the central nervous system of the patient delivering the pain relief sought.”
The second most important cannabinoid contained in cannabisisCBD, while the main one is THC. CBD has unbelievable pain relieving and anti-inflammatory properties and it comes from a completely natural source with a very small number of side effects, including the hallucinogenic effects that are commonly associated with THC.
Mr. Raymond C Dabney, CEO of Cannabis Science stated:
“The development of these 2 new pharmaceutical medicinal applications is just the tip of the iceberg for what we see as future for Cannabis Science. While we struggle to increase our land capacity for growth and facilities to produce our own product to supply the scientists with proprietary materials to make these formulations, we are also busy researching more possible needs for Cannabis related medical applications and developing the methods for delivery of those medications.”
Fibromyalgia is thought to affect up to 10% of people, with a huge number of sufferers who are not yet diagnosed. Nerve neuropathy diabetic pain affects a huge number of people all around the world, and this new treatment is going to be a massive step in the right direction towards limiting certain symptoms, and maybe even curing these diseases for good.
Mr. Dabney concludes:
“As more states nationally legislate for the legalization of cannabis and cannabis-derived medications, we here at the Cannabis Science are focused on developing pharmaceutical formulations and applications in order to supply the huge growing demand expected over the coming few years.”